Cardiovascular
Providing outstanding, innovative clinical care to every patient is our guiding principle. It is the foundation for everything we do and the driving force behind our Lillehei Heart Institute and University of Minnesota Physicians Cardiovascular Program. We are pleased to share with you the scope of our program for service to you, your patients, family members, and friends.
A study conducted by Rebecca Cogswell, MD and colleagues of a new transplant system implemented in 2018 demonstrated concerning early trends. Dr. Cogswell's findings, currently in press in the Journal of Heart and Lung Transplantation, will likely lead to changes in the new system.
Read the article
Research led by Assistant Professor Prabhjot Nijjar, MD, finds mindfulness-based stress reduction (MBSR) a "safe and well received secondary prevention strategy for cardiac patients." Read the article
Dr. Chen was part of an AHA group charged with summarizing current knowledge on the prevalence, clinical significance, and management of subclinical atrial fibrillation. Read the article
There is no other organization in the world that has had a greater impact in the battle against heart disease than the University of Minnesota. For more than six decades, we have been known throughout the world for our leadership and innovation in the treatment of cardiovascular disease. We have earned this reputation by demonstrating time and again that what others say is “impossible” can become a routine reality at the University of Minnesota. As a result of our bold leadership, millions of lives have been saved, entire industries have been launched and the face of medicine has been profoundly improved.
We stand proudly on the shoulders of giants like C. Walton Lillehei. As the discoverers in a new era of cardiovascular medicine, we are focused on solving huge and complex issues that require revolutionary approaches and endless creativity.
We believe detecting heart disease after it occurs isn’t good enough. At our Rasmussen Center for Cardiovascular Disease Prevention, we can detect disease before any symptoms ever appear and we treat it so that it can be prevented altogether. There is no other resource like this in the U.S.
We are unlocking the heart’s ability to heal itself and tailoring our therapies to each patient’s individual genetic makeup. In partnership with the many outstanding medical device companies in our state, we are engineering new devices that will improve heart function. This kind of partnership is the very foundation of the University of Minnesota. It is how we research and discover, how we teach and learn, and how we reach out to our communities. We collaborate with our colleagues in public health, imaging, engineering and countless other fields to learn from one another’s work and accelerate discovery across disciplines.
And the results speak for themselves. Our faculty innovations have produced more than 90 patents in the past 15 years. These innovations have fueled a 390% increase in annual external grant funding and a total of $45 million over the past four years. This is a powerful testament to the quality of our work and our future potential.
When others say it can’t be done, we say “yes.” We say “yes” to bold ideas; we say “yes” to creativity and innovation; we say “yes” to results.
That is what has always made us a leader and what will enable us to achieve the ultimate goal of curing heart disease altogether.
The Cardiovascular Division provides world-class innovation and first-class patient care at the University of Minnesota.
Heart patient Susan and her family share their experiences with the University of Minnesota’s cardiovascular team.